Sale!

Bordetella Multiplex Bordetella Pertussis Legionella Pneumophila Klebsiella Pneumonia Detection and Differentiation RNA Detection Qualitative Test Cost

Original price was: 2,800 د.إ.Current price is: 2,380 د.إ.

-15%

The “Bordetella Multiplex Bordetella Pertussis Legionella Pneumophila Klebsiella Pneumonia Detection and Differentiation RNA Detection Qualitative Test” is a sophisticated diagnostic assay offered by DNA Labs UAE. Priced at 2380 AED, this test is designed to accurately identify and differentiate between several critical respiratory pathogens, including Bordetella pertussis, Bordetella species, Legionella pneumophila, and Klebsiella pneumoniae, through RNA detection.

Utilizing cutting-edge molecular techniques, this qualitative test amplifies and detects specific RNA sequences unique to each of these pathogens, providing a precise diagnosis. This is particularly vital for implementing the appropriate treatment strategies and managing public health concerns, given the varying degrees of severity and treatment protocols for infections caused by these bacteria.

The test is especially valuable in clinical settings where rapid and accurate identification of these pathogens is necessary to manage and control outbreaks effectively. By offering this test, DNA Labs UAE plays a crucial role in enhancing patient care and contributing to the broader public health efforts in the region.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Bordetella Multiplex Bordetella pertussis Legionella pneumophilia Klabsiella pneumonia Detection and Differentiation RNA Detection Qualitative Test

At DNA Labs UAE, we offer the Bordetella Multiplex Bordetella pertussis Legionella pneumophilia Klabsiella pneumonia Detection and Differentiation RNA Detection Qualitative Test at a cost of AED 2380.0.

Test Details

The Bordetella Multiplex RNA Detection Test is a qualitative test used to detect and differentiate three different types of bacteria: Bordetella pertussis, Legionella pneumophila, and Klebsiella pneumoniae. These bacteria can cause respiratory infections, with Bordetella pertussis being the causative agent of whooping cough, Legionella pneumophila causing Legionnaires’ disease, and Klebsiella pneumoniae causing pneumonia.

The test specifically detects the RNA (ribonucleic acid) of these bacteria, which is an important component of their genetic material. RNA detection allows for the identification of the bacteria based on their unique genetic sequences.

The test is performed on a patient sample, usually obtained from the respiratory tract, such as sputum or nasopharyngeal swabs. The sample is processed to extract the RNA, which is then amplified using a technique called reverse transcription polymerase chain reaction (RT-PCR). This amplification step allows for the detection of very low levels of bacterial RNA in the sample.

The amplified RNA is then analyzed using specific probes or primers that target the genetic sequences of the three bacteria. If any of the target bacteria are present in the sample, their RNA will bind to the probes or primers, resulting in a positive signal.

The test provides a qualitative result, indicating whether the target bacteria are present or not. It does not provide information on the bacterial load or the severity of the infection.

The Bordetella Multiplex RNA Detection Test is a valuable tool in the diagnosis and management of respiratory infections caused by these bacteria. It allows for the rapid and accurate identification of the specific bacteria, which can guide appropriate treatment and infection control measures.

Test Components and Price

The test components include:

  • Bordetella Multiplex Bordetella pertussis Legionella pneumophilia Klabsiella pneumonia Detection and Differentiation RNA Detection Qualitative Test

The cost of the test is AED 2380.0.

Sample Condition

The sample conditions accepted for this test are:

  • Nasopharyngeal secretions
  • Swabs
  • Oral/rectal swabs
  • Necropsy samples
  • Blood
  • Urine
  • Sputum
  • Throat swab
  • Bronchoalveolar lavage samples
  • Lung tissue

Report Delivery

The report will be delivered within the following timeframes:

  • Email: 48 hours
  • On phone: 36 hours

Method

The test is performed using the Real Time PCR method.

Test Type

The test type is Viral.

Doctor

The test is performed under the supervision of a Physician.

Test Department

The test is conducted in the Genetics department.

Pre Test Information

Prior to taking the test, patients are required to sign a Consent document and bring any clinical history of the patient for Bordetella Multiplex (Bordetella pertussis, Legionella pneumophilia, Klabsiella pneumonia) Detection & Differentiation (RNA Detection) Qualitative Test.

Test Name Bordetella Multiplex Bordetella pertussisLegionella pneumophiliaKlabsiella pneumonia Detection and Differentiation RNA Detection Qualitative Test
Components
Price 2380.0 AED
Sample Condition Nasopharyngeal secretions, swabs, Oral\/rectal swabs and necropsy samples. Blood,Urine, Sputum, throat swab, and bronchoalveolar lavage samples, lung tissue,etc.
Report Delivery 4th Working Day Email : 48 hours.On phone : 36 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forBordetella Multiplex ( Bordetella pertussis,Legionella pneumophilia,,Klabsiella pneumonia ) Detection & Differentiation (RNA Detection) QualitativeTest
Test Details

The Bordetella Multiplex RNA Detection Test is a qualitative test used to detect and differentiate three different types of bacteria: Bordetella pertussis, Legionella pneumophila, and Klebsiella pneumoniae. These bacteria can cause respiratory infections, with Bordetella pertussis being the causative agent of whooping cough, Legionella pneumophila causing Legionnaires’ disease, and Klebsiella pneumoniae causing pneumonia.

The test specifically detects the RNA (ribonucleic acid) of these bacteria, which is an important component of their genetic material. RNA detection allows for the identification of the bacteria based on their unique genetic sequences.

The test is performed on a patient sample, usually obtained from the respiratory tract, such as sputum or nasopharyngeal swabs. The sample is processed to extract the RNA, which is then amplified using a technique called reverse transcription polymerase chain reaction (RT-PCR). This amplification step allows for the detection of very low levels of bacterial RNA in the sample.

The amplified RNA is then analyzed using specific probes or primers that target the genetic sequences of the three bacteria. If any of the target bacteria are present in the sample, their RNA will bind to the probes or primers, resulting in a positive signal.

The test provides a qualitative result, indicating whether the target bacteria are present or not. It does not provide information on the bacterial load or the severity of the infection.

The Bordetella Multiplex RNA Detection Test is a valuable tool in the diagnosis and management of respiratory infections caused by these bacteria. It allows for the rapid and accurate identification of the specific bacteria, which can guide appropriate treatment and infection control measures.